This interview with thought leader Michael Dahan, MD, FRCS, FACOG explores new technologies and improvements in the field of ART as well as how increasing access to fertility treatment for all patients will change and improve the field.
This interview is supported by an educational grant from Merck KGaA, Darmstadt, Germany.